The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date

• Egile Nagusiak: Antza C (Egilea), Nirantharakumar K (Egilea), Doundoulakis I (Egilea), Tahrani AA (Egilea), Toulis KA (Egilea)
• Formatua: Liburua
• Argitaratua: Dove Medical Press, 2019-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Christina Antza,1,* Krishnarajah Nirantharakumar,2,* Ioannis Doundoulakis,3 Abd A Tahrani,4–6 Konstantinos A Toulis2,313rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University, Thessaloniki, Greece; 2Institute of Applied Health Research, University of Birmingham, Bi...